172 related articles for article (PubMed ID: 31803620)
1. Identification of Subtype-Specific Three-Gene Signature for Prognostic Prediction in Diffuse Type Gastric Cancer.
Bao B; Zheng C; Yang B; Jin Y; Hou K; Li Z; Zheng X; Yu S; Zhang X; Fan Y; Qu X; Liu Y; Che X
Front Oncol; 2019; 9():1243. PubMed ID: 31803620
[TBL] [Abstract][Full Text] [Related]
2. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.
Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X
Front Immunol; 2021; 12():651033. PubMed ID: 34054812
[TBL] [Abstract][Full Text] [Related]
3. A nine-consensus-prognostic -gene-based prognostic signature, recognizing the dichotomized subgroups of gastric cancer patients with different clinical outcomes and therapeutic strategies.
Ji D; Yang Y; Zhou F; Li C
Front Genet; 2022; 13():909175. PubMed ID: 36226177
[No Abstract] [Full Text] [Related]
4. FMO family may serve as novel marker and potential therapeutic target for the peritoneal metastasis in gastric cancer.
Gong X; Hou D; Zhou S; Tan J; Zhong G; Yang B; Xie L; Han F; Zhong L
Front Oncol; 2023; 13():1144775. PubMed ID: 37274237
[TBL] [Abstract][Full Text] [Related]
5. LMOD1, an oncogene associated with Lauren classification, regulates the metastasis of gastric cancer cells through the FAK-AKT/mTOR pathway.
Tan Y; Chen Q; Pan S; An W; Xu H; Xing Y; Zhang J
BMC Cancer; 2022 Apr; 22(1):474. PubMed ID: 35488236
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Two-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival in Diffuse-Type Gastric Cancer.
Chen S; Xu J; Yin S; Wang H; Liu G; Jin X; Zhang J; Wang H; Wang H; Li H; Liang J; He Y; Zhang C
Curr Oncol; 2022 Dec; 30(1):171-183. PubMed ID: 36661663
[TBL] [Abstract][Full Text] [Related]
7. Identification of a molecular signature of prognostic subtypes in diffuse-type gastric cancer.
Kim SK; Kim HJ; Park JL; Heo H; Kim SY; Lee SI; Song KS; Kim WH; Kim YS
Gastric Cancer; 2020 May; 23(3):473-482. PubMed ID: 31773340
[TBL] [Abstract][Full Text] [Related]
8. High Level of Legumain Was Correlated With Worse Prognosis and Peritoneal Metastasis in Gastric Cancer Patients.
Wang Y; Zhang S; Wang H; Cui Y; Wang Z; Cheng X; Li W; Hou J; Ji Y; Liu T
Front Oncol; 2020; 10():966. PubMed ID: 32766126
[No Abstract] [Full Text] [Related]
9. Identification of subtype-specific genes signature by WGCNA for prognostic prediction in diffuse type gastric cancer.
Zhou Q; Zhou LQ; Li SH; Yuan YW; Liu L; Wang JL; Wu DZ; Wu Y; Xin L
Aging (Albany NY); 2020 Sep; 12(17):17418-17435. PubMed ID: 32915770
[TBL] [Abstract][Full Text] [Related]
10. A Wnt-related gene expression signature to improve the prediction of prognosis and tumor microenvironment in gastric cancer.
Kong S; Li Z; Wang Y; Zhang Z; Jia X; Gao X; Cong B; Zhang F; Zhang J; Zheng C
Front Genet; 2022; 13():1035099. PubMed ID: 36561311
[No Abstract] [Full Text] [Related]
11. [Establishment of risk evaluation model of peritoneal metastasis in gastric cancer and its predictive value].
Zhao J; Zhou R; Zhang Q; Shu P; Li H; Wang X; Shen Z; Liu F; Chen W; Qin J; Sun Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):47-52. PubMed ID: 28105619
[TBL] [Abstract][Full Text] [Related]
12. LPPR4 promotes peritoneal metastasis via Sp1/integrin α/FAK signaling in gastric cancer.
Zang D; Zhang C; Li C; Fan Y; Li Z; Hou K; Che X; Liu Y; Qu X
Am J Cancer Res; 2020; 10(3):1026-1044. PubMed ID: 32266108
[TBL] [Abstract][Full Text] [Related]
13. Integrated Analysis Identifies Molecular Signatures and Specific Prognostic Factors for Different Gastric Cancer Subtypes.
Min L; Zhao Y; Zhu S; Qiu X; Cheng R; Xing J; Shao L; Guo S; Zhang S
Transl Oncol; 2017 Feb; 10(1):99-107. PubMed ID: 28013168
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes in Gastric Cancer.
Wei XL; Luo TQ; Li JN; Xue ZC; Wang Y; Zhang Y; Chen YB; Peng C
Front Mol Biosci; 2021; 8():691143. PubMed ID: 34277706
[No Abstract] [Full Text] [Related]
15. Clinicopathological differences, risk factors and prognostic scores for western patients with intestinal and diffuse-type gastric cancer.
Díaz Del Arco C; Estrada Muñoz L; Ortega Medina L; Molina Roldán E; Cerón Nieto MÁ; García Gómez de Las Heras S; Fernández Aceñero MJ
World J Gastrointest Oncol; 2022 Jun; 14(6):1162-1174. PubMed ID: 35949214
[TBL] [Abstract][Full Text] [Related]
16. Predicting Peritoneal Dissemination of Gastric Cancer in the Era of Precision Medicine: Molecular Characterization and Biomarkers.
Chen Y; Zhou Q; Wang H; Zhuo W; Ding Y; Lu J; Wu G; Xu N; Teng L
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32785164
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
18. Positive Phospho-Focal Adhesion Kinase in Gastric Cancer Associates With Poor Prognosis After Curative Resection.
Peng K; Li S; Li Q; Zhang C; Yuan Y; Liu M; Zhang L; Wang Y; Yu S; Zhang H; Liu T
Front Oncol; 2022; 12():953938. PubMed ID: 35982966
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis-Related Gene Expression Signatures Predicting Prognosis in Gastric Cancer Patients.
Ren H; Zhu J; Yu H; Bazhin AV; Westphalen CB; Renz BW; Jacob SN; Lampert C; Werner J; Angele MK; Bösch F
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33302481
[TBL] [Abstract][Full Text] [Related]
20. Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma.
Li W; Chen QF; Huang T; Wu P; Shen L; Huang ZL
Front Oncol; 2020; 10():780. PubMed ID: 32587825
[No Abstract] [Full Text] [Related]
[Next] [New Search]
